nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

01.02.2020 | Otology

Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug

verfasst von: E. Domínguez-Durán, M. A. Montilla-Ibáñez, M. G. Álvarez-Morujo de Sande, E. Domènech-Vadillo, C. Bécares-Martínez, R. González-Aguado, G. Guerra-Jiménez

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Vestibular migraine (VM) consists of recurrent episodes of vestibular symptoms that are accompanied by migraine in at least 50% of the episodes. The criteria of the Bárány Society include two diagnostic categories: “actual” vestibular migraine and probable vestibular migraine. There is a wide range of drugs that can be prescribed for the prophylactic treatment of VM, but recommendations for the selection of the most appropriate drug are currently lacking.

Objective

To measure the extent to which the prophylactic treatment of VM reduces vestibular symptoms, headache and the number of crises depending on the diagnostic category of the Bárány Society and the drug used for prophylaxis.

Material and methods

This is a multicenter prospective study. Patients with VM who presented to any of the participating centers and who subsequently met the VM criteria were prescribed one of the following types of prophylaxis: acetazolamide, amitriptyline, flunarizine, propranolol or topiramate. Patients were called back for a follow-up visit 5 weeks later. This allowed the intensity of vestibular symptoms, headache and the number of crises before and during treatment to be compared.

Results

31 Patients met the inclusion criteria. During the treatment, all the measured variables decreased significantly. In a visual analogue scale, the intensity of vestibular symptoms decreased by 45.8 points, the intensity of headache decreased by 47.8 points and patients suffered from 15.6 less monthly crises compared to the period before the treatment. No significant between-group differences were found when patients were divided based on their diagnostic category or the choice of prophylaxis prescribed to them.

Conclusion

The treatment of VM produces a reduction of symptoms and crises with no significant differences based on patients’ diagnostic categories or the choice of prophylaxis prescribed to them.

Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J et al (2012) Vestibular migraine: diagnostic criteria. J Vestib Res Equilib Orientat 22(4):167–172CrossRef

Neuhauser HK, Radtke A, von Brevern M, Feldmann M, Lezius F, Ziese T et al (2006) Migrainous vertigo: prevalence and impact on quality of life. Neurology 67(6):1028–1033CrossRef

Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia Int J Headache 38(1):1–211.

Maldonado Fernández M, Birdi JS, Irving GJ, Murdin L, Kivekäs I, Strupp M (2015) Pharmacological agents for the prevention of vestibular migraine. Cochrane Database Syst Rev. 21(6):CD010600.

Burton M, Firkins L, James LA (2011) Priority setting partnership. Ear, nose and throat (aspects of balance) top 10. https://www.jla.nihr.ac.uk/priority-setting-partnerships/ear-nose-and-throat-aspects-of-balance/top-10-priorities/. Accessed 17 Aug 2019

Salviz M, Yuce T, Acar H, Karatas A, Acikalin RM (2016) Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial. The Laryngoscope 126(1):169–174CrossRef

Salmito MC, Duarte JA, Morganti LOG, Brandão PVC, Nakao BH, Villa TR et al (2017) Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol 83(4):404–410CrossRef

Liu F, Ma T, Che X, Wang Q, Yu S (2017) The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Front Neurol 8:524CrossRef

Domínguez-Durán E, Baños-López P, Martín-Castillo E, Galera-Ruiz H (2019) Inter-rater agreement in the choice of prophylactic treatment for vestibular migraine and role of an assisted algorithm for this choice. Acta Otorrinolaringol Esp

10.

Domínguez-Durán E, Baños-López P, Martín-Castillo E (2019) Migratron: Algoritmo asistido para la elección de tratamiento profiláctico en la migraña vestibular. https://migratron.com/#/. Accessed 5 Jan 2019

11.

Zhao PP, Xu XR, Jin ZG, Zhang Y, Li YJ (2019) Analysis of clinical features of secondary benign paroxysmal positional vertigo. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi J Clin Otorhinolaryngol Head Neck Surg 33(3):220–224

12.

von Brevern M, Bertholon P, Brandt T, Fife T, Imai T, Nuti D et al (2015) Benign paroxysmal positional vertigo: diagnostic criteria. J Vestib Res Equilib Orientat 25(3–4):105–117CrossRef

13.

Álvarez-Morujo de Sande MG, González-Aguado R, Guerra-Jiménez G, Domènech-Vadillo E, Galera-Ruiz H, Figuerola-Massana E et al (2019) Probable benign paroxysmal positional vertigo, spontaneously resolved: incidence in medical practice, patients’ characteristics and the natural course. J Otol 14(3):111–116CrossRef

14.

von Brevern M, Radtke A, Clarke AH, Lempert T (2004) Migrainous vertigo presenting as episodic positional vertigo. Neurology 62(3):469–472CrossRef

15.

Mallery RM, Friedman DI, Liu GT (2014) Headache and the pseudotumor cerebri syndrome. Curr Pain Headache Rep 18(9):446CrossRef

16.

Stevens SM, Rizk HG, Golnik K, Andaluz N, Samy RN, Meyer TA et al (2018) Idiopathic intracranial hypertension: contemporary review and implications for the otolaryngologist. The Laryngoscope 128(1):248–256CrossRef

17.

Lopez-Escamez JA, Carey J, Chung W-H, Goebel JA, Magnusson M, Mandalà M et al (2015) Diagnostic criteria for Menière’s disease. J Vestib Res Equilib Orientat 25(1):1–7CrossRef

18.

Strupp M, Lopez-Escamez JA, Kim J-S, Straumann D, Jen JC, Carey J et al (2016) Vestibular paroxysmia: diagnostic criteria. J Vestib Res Equilib Orientat 26(5–6):409–415

Titel: Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug
verfasst von: E. Domínguez-Durán
M. A. Montilla-Ibáñez
M. G. Álvarez-Morujo de Sande
E. Domènech-Vadillo
C. Bécares-Martínez
R. González-Aguado
G. Guerra-Jiménez
Publikationsdatum: 01.02.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 4/2020
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-020-05802-5

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug